VEEV's split from Salesforce sets the stage for a high-stakes CRM showdown as both firms double down on life sciences innovation.

Conestoga trailed in Q2 as AI-fueled stocks surged, but stayed focused on quality mid caps. See how they’re positioning for long-term growth over hype.

Discover how financial advisors can leverage the right tech tools to streamline operations, enhance client experiences, and ...

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 ...

IGV ETF is an attractive option for exposure to leading software stocks, which remain a long-term growth industry. Read more ...

LogMeOnce is a powerful password management program, and would suit anyone looking for a powerful, versatile password ...

Merck has officially embraced Veeva Systems' Vault CRM, sending positive ripples across Wall Street. The move, hailed as a ...

Salesforce's trading volume exploded on July 21, 2025, hitting 1.759 billion. It ranked 35th for the day, even as the stock ...

Veeva Systems (VEEV) announced on Wednesday that Merck (MRK), a major pharmaceutical company, has committed to its Vault CRM.

We are excited to expand our strategic partnership with Veeva by moving to Vault CRM,” said Dave Williams, executive vice ...

Veeva Systems (NYSE: VEEV) today announced that Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ...